Interferon beta-1a combination with azathioprine and low-dose steroids (ASA study) for relapsing-remitting multiple sclerosis clinical and MRIdata from 2-years double blind, randomised, placebo controled study

Abstrakt

interferon beta-1a, azathioprine, low dose steroids, relapsing-remitting multiple sclerosis, MRI, ASA study